KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Liabilities and Shareholders Equity (2016 - 2025)

Chemed (CHE) has 17 years of Liabilities and Shareholders Equity data on record, last reported at $1.5 billion in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 7.81% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $6.6 billion, down 4.27%, while the annual FY2025 figure was $1.5 billion, 7.81% down from the prior year.
  • Liabilities and Shareholders Equity reached $1.5 billion in Q4 2025 per CHE's latest filing, down from $1.6 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $1.8 billion in Q3 2024 and bottomed at $1.3 billion in Q1 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: dropped 10.45% in 2022, then grew 20.71% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.3 billion in 2021, then grew by 7.39% to $1.4 billion in 2022, then grew by 15.68% to $1.7 billion in 2023, then rose by 0.03% to $1.7 billion in 2024, then fell by 7.81% to $1.5 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $1.5 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.7 billion in Q2 2025.